About Mobidiag
Mobidiag is a Healthcare company based in Espoo (Finland) founded in 2000, and was acquired by Hologic in April 2021. In vitro diagnostics for infectious diseases are developed and provided. Mobidiag has raised $16.14 million across 7 funding rounds from investors including Hologic, European Investment Bank and Business Finland. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging. Its legal entity is Mobidiag Oy.
Company details
Mobidiag was founded in 2000 in Espoo, Finland, and operates in the in vitro diagnostics sector focused on infectious diseases. Rapid multiplex PCR-based solutions, such as the Amplidiag product line, are offered for gastrointestinal infections including H. pylori, C. difficile, and various parasites, bacteria, and viruses. Instruments like Amplidiag Easy and Novodiag are utilized for diagnostics, alongside the Prove-it kits for bone, joint, and herpes conditions.
- Headquarters Espoo, Finland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website mobidiag.com
- Social LinkedIn X Facebook
- Acquired by Hologic (Apr 2021)
- Legal Name Mobidiag Oy
- Annual Revenue$11.13 M (USD)-67as on Sep 30, 2023
- Net Profit-$154.97 M (USD)-167as on Sep 30, 2023
- EBITDA-$154.97 M (USD)-167as on Sep 30, 2023
- Total Equity Funding$16.14M (USD)
in 7 rounds
- Latest Funding Round$1.68M (USD), Debt – Conventional
Jan 2020
- InvestorsHologic
& 4 more
- Acquired byHologic
(Apr 2021)
Funding Insights of Mobidiag
Mobidiag has successfully raised a total of $16.14M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.68 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.14M
- Total Rounds 7
- Last Round Debt – Conventional — $1.68M
- First Round $4.24M
(Apr 2017)
- Investors Count 4
All 7 funding rounds of Mobidiag with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $1.68M | Debt – Conventional | – | – | – |
| May 2019 | $28.08M | Debt – Conventional | – | – | |
| Feb 2019 | $11.45M | Series B | – | Autobio | – |
| Nov 2018 | $16.95M | Debt – Conventional | – | – | |
| May 2018 | $1.75M | Debt – Conventional | – | – | |
| May 2018 | $4.69M | Series A | – | Springvest | – |
| Apr 2017 | $4.24M | Debt – Conventional | – | – |
5 investors in total: 5 institutional.
Investors in Mobidiag
Mobidiag has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, European Investment Bank and Business Finland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Springvest is recognized as a leading growth investment service in Finland. | 2012 | springvest.fi | Helsinki, Finland | |
| autobio-diagnostics.com | ||||
Innovation, internationalization, and investment support for businesses is provided. | 1983 | businessfinland.fi | Helsinki, Finland | |
Diagnostic and surgical products for women's healthcare are provided. | 1985 | hologic.com | Marlborough, United States |
Investor details for Mobidiag
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mobidiag
9 people are tracked at Mobidiag (2 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Jari Järvisalo | Director Software Engineering | Leadership |
Tuomas Tenkanen | Chief Executive Officer | Leadership |
Heli Haakana | Quality Control Manager | Team |
Minna Nykter | Senior Quality Specialist | Team |
Anne Ala-Pöntiö | Lead Quality Engineer | Team |
Matti Helin | Senior Software Engineer | Team |
Janica Wakkinen | Senior Supplier Quality Engineer | Team |
Pekka Savander | Senior Engineering Manager | Team |
Olli Sjöberg | Senior Software Engineer | Team |
Complete people profiles for Mobidiag
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mobidiag
4 dated milestones of Mobidiag across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Mobidiag is founded.
- Funding First funding round of $4.2M.
- Funding Latest funding round, Debt – Conventional, of $1.7M.
- Exit Acquired by Hologic.
Web traffic of Mobidiag
Websites that share an audience with Mobidiag (mobidiag.com).
Websites whose visitors overlap most with Mobidiag. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| spectraldx.com | 100% | 2.6K | #7,409,044 | View details | |
aic.cuhk.edu.hk | aic.cuhk.edu.hk | 76% | – | ||
sepsistrust.org | sepsistrust.org | 62% | #988,777 | – | |
sepsisalliance.org | sepsisalliance.org | 62% | – | ||
sepsisforum.org | sepsisforum.org | 62% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Mobidiag
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mobidiag
Complete news archive for Mobidiag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mobidiag
Mobidiag was founded in 2000 and raised its 1st funding round 17 years after it was founded.
Mobidiag is headquartered in Espoo, Finland.
Mobidiag is a funded company, having raised a total of $16.14M across 7 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $4.24M, raised on Apr 2017.
Annual revenue of Mobidiag is $11.13M as on Sep 30, 2023.
Mobidiag was founded in 2000 in Espoo, Finland, and operates in the in vitro diagnostics sector focused on infectious diseases. Rapid multiplex PCR-based solutions, such as the Amplidiag product line, are offered for gastrointestinal infections including H. pylori, C. difficile, and various parasites, bacteria, and viruses. Instruments like Amplidiag Easy and Novodiag are utilized for diagnostics, alongside the Prove-it kits for bone, joint, and herpes conditions.
Mobidiag has 5 investors. Key investors include Hologic, European Investment Bank, Business Finland, Autobio, and Springvest.
Mobidiag operates through Mobidiag Oy.
Yes. Mobidiag was acquired by Hologic in April 2021.